Abstract PS18-02: Highly multiplexed tissue-based cyclic immunofluorescence (t-CyCIF) for precision oncology identifies novel patterns of HER2 heterogeneity in breast cancer
Jennifer L. Guerriero(Brigham and Women's Hospital), Elizabeth A. Mittendorf(Beth Israel Deaconess Medical Center), Shaolin Mei(Harvard University), Jia‐Ren Lin(Harvard University), Stuart J. Schnitt(Brigham and Women's Hospital), Peter K. Sorger(Harvard University Press), Ricardo Pastorello(Dana-Farber Cancer Institute), Ziming Du(Fuyang City People's Hospital), Deborah Dillon(Brigham and Women's Hospital), Krishan Taneja(Brigham and Women's Hospital), Sandro Santagata(Harvard University)
Cited by 1
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.5k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k